Healthcare
What is Ego Death? – A Look into a Popular Reason Why People are Taking Psychedelics
Is an ego death for everyone or just the psychedelics crowd?
What Is ‘Ego Death’? – A Look Into a Popular Reason People are Taking Psychedelics
Taking psychedelics for spiritual purposes can leave a humbling mark among some of those who take it. Psilocybin magic mushrooms, LSD, ayahuasca, and DMT are among the psychedelics that are taken for spiritual reasons.
It forces one to question their life, look at it without the mask that you work so hard to display to other people. A mask that you have kept, as well as opinions and habits you have formed throughout your lifetime as a result of your upbringing, family, relationships, and environment. Oftentimes, the way we look at life can be flawed and biased because of these factors, but that is completely normal. But when these factors, such as traumatic life experiences and narcissistic parents to name a few, result in a mentality and behavior that harms ourselves and others, then it may be time to consider a reevaluation through ego death.
Sigmund Freud, the famous Austrian neurologist and father of psychoanalysis, developed his personality theory back in 1923. This is where he discusses the ego as part of the personality, and we know it today to be responsible for balancing the id, the most basic component of personality, with superego, which when combined enable us to conform to reality. The ego is also influenced directly by our own external world.
Some people have healthy egos, while others – those that can benefit from psychedelic therapy – may not. It’s what we know ourselves to be, and in some cases this can lead to substance abuse, eating disorders, and other types of mental disorders that we associate ourselves with subconsciously.
Ego Death May Not Be Blissful
Ego death, also known as ego dissolution, is widely known as the experience wherein one loses the sense of self. Psychedelics are a very useful way to induce this.
Unlike other people who trip on psychedelics for its blissful effects, those who undergo ego death may not find it pleasant at all. It could be cathartic to some, it may even cause temporary sadness followed by feeling like a heavy load has been lifted from your shoulders. It’s also common for many to feel like one was actually dying, but instead of a physical death, one goes through a death of self and identity.
For those who have never tried psychedelics, this may seem like the antithesis of recreational drugs. But this is where the mental health benefits of psychedelics comes in: people actually seek out ego death purposefully especially when they are suffering from alcoholism, addiction, trauma, depression, and other psychological disorders.
There are many ways to describe ego death, oftentimes varying from one person to another. In essence, experiencing ego death allows us to break free from the identity and opinions we have formed about ourselves and the world. It can be painful when psychedelics forces us to come face to face with parts of ourselves that we didn’t want to look at before, but in doing so, it helps us prepare for the future in a different way – and have the chance to live a much better life.
Ego death has sparked an interest among scientists and researchers. They have found that there is unusual activity going on in the brain’s hippocampus, which is the region of the brain where memories are stored and retrieved. Experts hypothesize that when ego death occurs due to psychedelic consumption, the transport of information from the hippocampus to other parts of the brain are interrupted. As a result, autobiographical memory temporarily stops working.
In a 2015 study out of Imperial College, researchers found that ego death induced by psilocybin was found to cause “decreased functional connectivity between the medial temporal lobe and high-level cortical regions,”. In addition, they found that “individuals with lower diversity of executive network nodes were more likely to experience ego-dissolution under psilocybin.”
Another study from 2018 analyzed ayahuasca ceremony participants. The researchers assessed ego dissolution among participants by asking them to fill out a questionnaire gauging both short and long term changes in their behaviors and mood. They found that “ratings of depression and stress significantly decreased…. Convergent thinking improved.” Furthermore, researchers found that: “Changes in affect, satisfaction with life, and mindfulness were significantly correlated to the level of ego dissolution experienced during the ayahuasca ceremony.”
Then in 2019, a study by researchers in Switzerland assessed 38 people on a 5 day silent retreat. Participants were randomly given either 21.82mg of psilocybin or a placebo. They were asked to continue their scheduled meditation and brain scans were taken before as well as after the retreat. The researchers discovered that after the retreat, participants who were given psilocybin displayed significant changes in the regions of the brain related to the DMN, which is evidence of ego death. Similar findings have been reported in other studies. Changes in brain connectivity such as these were associated with a mood improvement as well as positive changes in spirituality, attitudes about one’s self, and behavior.
No matter how you look at it, ego dissolution can be a truly powerful and life-changing experience. It has been known to have lasting psychological impacts which are not necessarily negative but perhaps – transcendent. Individuals can come out of psychedelic trips feeling more content, at peace, and knowing their strengths and weaknesses better. This whole experience will also enable you to let go and release trauma, grudges, anger, and other negative emotions in order to come out the other side from a place of peace and more love towards yourself, others, and the world as a whole.
Is an Ego Death for Everyone?
For many people, an ego death is a hallmark for taking psychedelics. One needs to take a significantly large dose, as opposed to a microdose, in order for this to occur. If you are at a crossroads in your life and are looking to make some big changes starting from within, try psychedelic-assisted psychotherapy. It might give you the ego death and new perspectives that you have needed this whole time.
Education News
AIIMS Gorakhpur Reservation Controversy: FIR Alleges Fake OBC Certificate Used Despite ₹80 Lakh Income
A major controversy has emerged at AIIMS Gorakhpur after allegations surfaced that reservation benefits were misused to secure a postgraduate medical seat. A criminal case has been registered against former AIIMS Gorakhpur Executive Director Dr. G.K. Pal and his son, Dr. Oro Prakash Pal, over the alleged use of a forged Other Backward Class (OBC) Non-Creamy Layer certificate for admission to an MD course.
The case has triggered widespread debate within medical and administrative circles, raising serious questions about transparency and oversight in admissions to premier medical institutions.
FIR Filed on Court’s Direction
The First Information Report (FIR) was registered at the AIIMS police station following directions from Chief Judicial Magistrate Tvishi Srivastava. According to the complaint, the alleged offence took place on August 30, 2024, when forged documents were purportedly used to obtain an MD seat under the OBC reservation quota.
Sources indicate that the matter was subsequently brought to the attention of the Union Ministry of Health, prompting internal reviews and administrative action.
Alleged Income Far Above Eligibility Threshold
Central to the allegations is the claim that Dr. G.K. Pal and his wife Parvati Pal have a combined annual income exceeding ₹80 lakh. Under existing reservation rules, families with such income levels are not eligible for OBC Non-Creamy Layer benefits.
Following the emergence of the controversy, Dr. Pal was first removed from his position at AIIMS Gorakhpur and later relieved of responsibilities at AIIMS Patna. He is currently posted at JIPMER Puducherry. With the registration of the FIR, officials suggest that further legal and departmental action may follow, depending on the outcome of the investigation.
Complaint Highlights Systemic Concerns
The complaint was filed by Ashutosh Kumar Mishra, a resident of Divyanagar in the Cantonment area. He alleged that the events related to the case occurred between January and September 2024. The complainant argued that misuse of reservation provisions by individuals in senior positions undermines the integrity of public institutions and erodes trust in the medical education system.
The case has reignited concerns over whether verification mechanisms for reservation certificates are robust enough, particularly in high-stakes admissions.
Impact on Medical Community
The allegations have sent shockwaves through the medical fraternity. Experts believe that if the claims are substantiated, the case could prompt a broader review of admission procedures and lead to stricter scrutiny of category certificates across institutions like AIIMS.
Authorities have stated that all relevant documents will be carefully examined before taking further steps. The outcome of the investigation is expected to have far-reaching implications for accountability and compliance in medical admissions.
Questions Await Answers
As the probe continues, several key issues remain unresolved: whether reservation norms were deliberately violated, how verification processes failed, and whether similar cases may surface in the future. For now, the focus remains on the investigation and its potential consequences.
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business2 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business2 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business2 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy